These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 34293856)
21. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity. Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122 [TBL] [Abstract][Full Text] [Related]
22. Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx and Arcoxia. Caturla F; Amat M; Reinoso RF; Córdoba M; Warrellow G Bioorg Med Chem Lett; 2006 Jun; 16(12):3209-12. PubMed ID: 16616494 [TBL] [Abstract][Full Text] [Related]
33. Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation. Yan XQ; Wang ZC; Zhang B; Qi PF; Li GG; Zhu HL Molecules; 2019 Apr; 24(9):. PubMed ID: 31052167 [TBL] [Abstract][Full Text] [Related]
34. Design and Synthesis of a Novel NIR Celecoxib-Based Fluorescent Probe for Cyclooxygenase-2 Targeted Bioimaging in Tumor Cells. Wang X; Wang L; Xie L; Xie Z; Li L; Bui D; Yin T; Gao S; Hu M Molecules; 2020 Sep; 25(18):. PubMed ID: 32899627 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors. Abdellatif KRA; Abdelgawad MA; Labib MB; Zidan TH Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28605057 [TBL] [Abstract][Full Text] [Related]
36. Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib. Sobolewski C; Legrand N Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356673 [TBL] [Abstract][Full Text] [Related]
37. Spectroscopic study on the interaction of celecoxib with human carbonic anhydrase II: thermodynamic characterization of the binding process. Mehrabi M; Ghobadi S; Khodarahmi R J Photochem Photobiol B; 2009 Dec; 97(3):161-8. PubMed ID: 19879770 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors. Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1. Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351 [TBL] [Abstract][Full Text] [Related]
40. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids. Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]